185 related articles for article (PubMed ID: 29800043)
1. The Microbiome and Risk for Atherosclerosis.
Komaroff AL
JAMA; 2018 Jun; 319(23):2381-2382. PubMed ID: 29800043
[No Abstract] [Full Text] [Related]
2. [Gut Microbiota and Internal Diseases: Update Information. Topics: V. Gut Microbiota: Topics in Various Medical Fields; 1. Does intestinal flora promote atherosclerosis?].
Yamashina A
Nihon Naika Gakkai Zasshi; 2015 Jan; 104(1):66-70. PubMed ID: 26571776
[No Abstract] [Full Text] [Related]
3. Risk factors for cardiovascular disease: a cautionary tale of diet-microbiome interactions.
Miller MJ
J Am Coll Nutr; 2013; 32(2):75-8. PubMed ID: 24015714
[No Abstract] [Full Text] [Related]
4. Mammalian-microbial cometabolism of L-carnitine in the context of atherosclerosis.
Claus SP
Cell Metab; 2014 Nov; 20(5):699-700. PubMed ID: 25440049
[TBL] [Abstract][Full Text] [Related]
5. Microbiome: Drugs for your bugs.
Nunes-Alves C
Nat Rev Microbiol; 2016 Feb; 14(2):62. PubMed ID: 26714432
[No Abstract] [Full Text] [Related]
6. Decompensated cirrhosis and microbiome interpretation.
Bajaj JS; Betrapally NS; Gillevet PM
Nature; 2015 Sep; 525(7569):E1-2. PubMed ID: 26381988
[No Abstract] [Full Text] [Related]
7. New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis.
Drosos I; Tavridou A; Kolios G
Metabolism; 2015 Apr; 64(4):476-81. PubMed ID: 25676802
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease: the diet-microbe morbid union.
Rak K; Rader DJ
Nature; 2011 Apr; 472(7341):40-1. PubMed ID: 21475185
[No Abstract] [Full Text] [Related]
9. Intestinal Microbiota Metabolism and Atherosclerosis.
Liu TX; Niu HT; Zhang SY
Chin Med J (Engl); 2015 Oct; 128(20):2805-11. PubMed ID: 26481750
[TBL] [Abstract][Full Text] [Related]
10. Gut-brain axis: how the microbiome influences anxiety and depression.
Foster JA; McVey Neufeld KA
Trends Neurosci; 2013 May; 36(5):305-12. PubMed ID: 23384445
[TBL] [Abstract][Full Text] [Related]
11. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
12. Lipid metabolism by gut microbes and atherosclerosis.
Loscalzo J
Circ Res; 2011 Jul; 109(2):127-9. PubMed ID: 21737814
[No Abstract] [Full Text] [Related]
13. MICROBIOME. Rethinking heritability of the microbiome.
van Opstal EJ; Bordenstein SR
Science; 2015 Sep; 349(6253):1172-3. PubMed ID: 26359393
[No Abstract] [Full Text] [Related]
14. Drug the Bug!
Jonsson AL; Bäckhed F
Cell; 2015 Dec; 163(7):1565-6. PubMed ID: 26687345
[TBL] [Abstract][Full Text] [Related]
15. Qin et al. reply.
Qin N; Le Chatelier E; Guo J; Prifti E; Li L; Ehrlich SD
Nature; 2015 Sep; 525(7569):E2-3. PubMed ID: 26381989
[No Abstract] [Full Text] [Related]
16. The gut microbiome and diet in psychiatry: focus on depression.
Dash S; Clarke G; Berk M; Jacka FN
Curr Opin Psychiatry; 2015 Jan; 28(1):1-6. PubMed ID: 25415497
[TBL] [Abstract][Full Text] [Related]
17. Cirrhosis and dysbiosis: New insights from next-generation sequencing.
Gorham J; Gleeson M
Hepatology; 2016 Jan; 63(1):336-8. PubMed ID: 26313376
[No Abstract] [Full Text] [Related]
18. Obesity, Asthma, and the Microbiome.
Cho Y; Shore SA
Physiology (Bethesda); 2016 Mar; 31(2):108-16. PubMed ID: 26889016
[TBL] [Abstract][Full Text] [Related]
19. The Intriguing Link between the Intestinal Microbiota and Cardiovascular Disease.
Lippi G; Danese E; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2017 Sep; 43(6):609-613. PubMed ID: 28293920
[TBL] [Abstract][Full Text] [Related]
20. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
Caesar R; Fåk F; Bäckhed F
J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
